Industry Research Reports
Global Cell therapy Processing Market Research Report 2026
Industry: Machinery & Equipment
Published Date: 2026-04-28
Pages: 124 Pages
Report ld: 6671000
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Cell therapy Processing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Cell therapy Processing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cell therapy Processing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Cell therapy Processing in Cardiovascular Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Cell therapy Processing include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc., Immodulon-Therapeutics, Immunomedics Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cell therapy Processing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell therapy Processing. The Cell therapy Processing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell therapy Processing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell therapy Processing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Anthrogenesis Corp.
- BioNTech
- Cell Ideas
- Epic Sciences
- Roche
- FuGENE
- IBC Pharmaceuticals Inc.
- Bluebird Bio Inc.
- Immodulon-Therapeutics
- Immunomedics Inc.
- Juno Therapeutics Inc.
- Medlmmune Inc.
- NeoStem Oncology
- Neurotech USA
- Novartis
- Persimmune Inc.
- Pluristem Therapeutics
- BioMed Valley Discoveries Inc.
- Regeneron Pharmaceuticals Inc.
- UCL Business PLC.
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Products
- Services
- Software
Segment by Application
- Cardiovascular Disease
- Bone Repair
- Neurological Disorders
- Skeletal Muscle RepairImmune Diseases
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell therapy Processing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell therapy Processing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Products
1.2.3 Services
1.2.4 Software
1.3 Market by Application
1.3.1 Global Cell therapy Processing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cardiovascular Disease
1.3.3 Bone Repair
1.3.4 Neurological Disorders
1.3.5 Skeletal Muscle RepairImmune Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell therapy Processing Market Perspective (2021–2032)
2.2 Global Cell therapy Processing Growth Trends by Region
2.2.1 Global Cell therapy Processing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell therapy Processing Historic Market Size by Region (2021–2026)
2.2.3 Cell therapy Processing Forecasted Market Size by Region (2027–2032)
2.3 Cell therapy Processing Market Dynamics
2.3.1 Cell therapy Processing Industry Trends
2.3.2 Cell therapy Processing Market Drivers
2.3.3 Cell therapy Processing Market Challenges
2.3.4 Cell therapy Processing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell therapy Processing Players by Revenue
3.1.1 Global Top Cell therapy Processing Players by Revenue (2021–2026)
3.1.2 Global Cell therapy Processing Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell therapy Processing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell therapy Processing Revenue
3.4 Global Cell therapy Processing Market Concentration Ratio
3.4.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 2025
3.5 Global Key Players of Cell therapy Processing Head Offices and Areas Served
3.6 Global Key Players of Cell therapy Processing, Products and Applications
3.7 Global Key Players of Cell therapy Processing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell therapy Processing Breakdown Data by Type
4.1 Global Cell therapy Processing Historic Market Size by Type (2021–2026)
4.2 Global Cell therapy Processing Forecasted Market Size by Type (2027–2032)
5 Cell therapy Processing Breakdown Data by Application
5.1 Global Cell therapy Processing Historic Market Size by Application (2021–2026)
5.2 Global Cell therapy Processing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell therapy Processing Market Size (2021–2032)
6.2 North America Cell therapy Processing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell therapy Processing Market Size by Country (2021–2026)
6.4 North America Cell therapy Processing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell therapy Processing Market Size (2021–2032)
7.2 Europe Cell therapy Processing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell therapy Processing Market Size by Country (2021–2026)
7.4 Europe Cell therapy Processing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell therapy Processing Market Size (2021–2032)
8.2 Asia-Pacific Cell therapy Processing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell therapy Processing Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell therapy Processing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell therapy Processing Market Size (2021–2032)
9.2 Latin America Cell therapy Processing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell therapy Processing Market Size by Country (2021–2026)
9.4 Latin America Cell therapy Processing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell therapy Processing Market Size (2021–2032)
10.2 Middle East & Africa Cell therapy Processing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell therapy Processing Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell therapy Processing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anthrogenesis Corp.
11.1.1 Anthrogenesis Corp. Company Details
11.1.2 Anthrogenesis Corp. Business Overview
11.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction
11.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2021–2026)
11.1.5 Anthrogenesis Corp. Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Cell therapy Processing Introduction
11.2.4 BioNTech Revenue in Cell therapy Processing Business (2021–2026)
11.2.5 BioNTech Recent Development
11.3 Cell Ideas
11.3.1 Cell Ideas Company Details
11.3.2 Cell Ideas Business Overview
11.3.3 Cell Ideas Cell therapy Processing Introduction
11.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2021–2026)
11.3.5 Cell Ideas Recent Development
11.4 Epic Sciences
11.4.1 Epic Sciences Company Details
11.4.2 Epic Sciences Business Overview
11.4.3 Epic Sciences Cell therapy Processing Introduction
11.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2021–2026)
11.4.5 Epic Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cell therapy Processing Introduction
11.5.4 Roche Revenue in Cell therapy Processing Business (2021–2026)
11.5.5 Roche Recent Development
11.6 FuGENE
11.6.1 FuGENE Company Details
11.6.2 FuGENE Business Overview
11.6.3 FuGENE Cell therapy Processing Introduction
11.6.4 FuGENE Revenue in Cell therapy Processing Business (2021–2026)
11.6.5 FuGENE Recent Development
11.7 IBC Pharmaceuticals Inc.
11.7.1 IBC Pharmaceuticals Inc. Company Details
11.7.2 IBC Pharmaceuticals Inc. Business Overview
11.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction
11.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.7.5 IBC Pharmaceuticals Inc. Recent Development
11.8 Bluebird Bio Inc.
11.8.1 Bluebird Bio Inc. Company Details
11.8.2 Bluebird Bio Inc. Business Overview
11.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction
11.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.8.5 Bluebird Bio Inc. Recent Development
11.9 Immodulon-Therapeutics
11.9.1 Immodulon-Therapeutics Company Details
11.9.2 Immodulon-Therapeutics Business Overview
11.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction
11.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2021–2026)
11.9.5 Immodulon-Therapeutics Recent Development
11.10 Immunomedics Inc.
11.10.1 Immunomedics Inc. Company Details
11.10.2 Immunomedics Inc. Business Overview
11.10.3 Immunomedics Inc. Cell therapy Processing Introduction
11.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.10.5 Immunomedics Inc. Recent Development
11.11 Juno Therapeutics Inc.
11.11.1 Juno Therapeutics Inc. Company Details
11.11.2 Juno Therapeutics Inc. Business Overview
11.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction
11.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.11.5 Juno Therapeutics Inc. Recent Development
11.12 Medlmmune Inc.
11.12.1 Medlmmune Inc. Company Details
11.12.2 Medlmmune Inc. Business Overview
11.12.3 Medlmmune Inc. Cell therapy Processing Introduction
11.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.12.5 Medlmmune Inc. Recent Development
11.13 NeoStem Oncology
11.13.1 NeoStem Oncology Company Details
11.13.2 NeoStem Oncology Business Overview
11.13.3 NeoStem Oncology Cell therapy Processing Introduction
11.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2021–2026)
11.13.5 NeoStem Oncology Recent Development
11.14 Neurotech USA
11.14.1 Neurotech USA Company Details
11.14.2 Neurotech USA Business Overview
11.14.3 Neurotech USA Cell therapy Processing Introduction
11.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2021–2026)
11.14.5 Neurotech USA Recent Development
11.15 Novartis
11.15.1 Novartis Company Details
11.15.2 Novartis Business Overview
11.15.3 Novartis Cell therapy Processing Introduction
11.15.4 Novartis Revenue in Cell therapy Processing Business (2021–2026)
11.15.5 Novartis Recent Development
11.16 Persimmune Inc.
11.16.1 Persimmune Inc. Company Details
11.16.2 Persimmune Inc. Business Overview
11.16.3 Persimmune Inc. Cell therapy Processing Introduction
11.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.16.5 Persimmune Inc. Recent Development
11.17 Pluristem Therapeutics
11.17.1 Pluristem Therapeutics Company Details
11.17.2 Pluristem Therapeutics Business Overview
11.17.3 Pluristem Therapeutics Cell therapy Processing Introduction
11.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2021–2026)
11.17.5 Pluristem Therapeutics Recent Development
11.18 BioMed Valley Discoveries Inc.
11.18.1 BioMed Valley Discoveries Inc. Company Details
11.18.2 BioMed Valley Discoveries Inc. Business Overview
11.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction
11.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.18.5 BioMed Valley Discoveries Inc. Recent Development
11.19 Regeneron Pharmaceuticals Inc.
11.19.1 Regeneron Pharmaceuticals Inc. Company Details
11.19.2 Regeneron Pharmaceuticals Inc. Business Overview
11.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction
11.19.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2021–2026)
11.19.5 Regeneron Pharmaceuticals Inc. Recent Development
11.20 UCL Business PLC.
11.20.1 UCL Business PLC. Company Details
11.20.2 UCL Business PLC. Business Overview
11.20.3 UCL Business PLC. Cell therapy Processing Introduction
11.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2021–2026)
11.20.5 UCL Business PLC. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Cell therapy Processing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Products
Table 3. Key Players of Services
Table 4. Key Players of Software
Table 5. Global Cell therapy Processing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Cell therapy Processing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Cell therapy Processing Market Size by Region (US$ Million), 2021–2026
Table 8. Global Cell therapy Processing Market Share by Region (2021–2026)
Table 9. Global Cell therapy Processing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Cell therapy Processing Market Share by Region (2027–2032)
Table 11. Cell therapy Processing Market Trends
Table 12. Cell therapy Processing Market Drivers
Table 13. Cell therapy Processing Market Challenges
Table 14. Cell therapy Processing Market Restraints
Table 15. Global Cell therapy Processing Revenue by Players (US$ Million), 2021–2026
Table 16. Global Cell therapy Processing Market Share by Players (2021–2026)
Table 17. Global Top Cell therapy Processing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell therapy Processing Revenue, 2025
Table 18. Ranking of Global Top Cell therapy Processing Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Cell therapy Processing Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Cell therapy Processing, Headquarters and Area Served
Table 21. Global Key Players of Cell therapy Processing, Products and Applications
Table 22. Global Key Players of Cell therapy Processing, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Cell therapy Processing Market Size by Type (US$ Million), 2021–2026
Table 25. Global Cell therapy Processing Revenue Market Share by Type (2021–2026)
Table 26. Global Cell therapy Processing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Cell therapy Processing Revenue Market Share by Type (2027–2032)
Table 28. Global Cell therapy Processing Market Size by Application (US$ Million), 2021–2026
Table 29. Global Cell therapy Processing Revenue Market Share by Application (2021–2026)
Table 30. Global Cell therapy Processing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Cell therapy Processing Revenue Market Share by Application (2027–2032)
Table 32. North America Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Cell therapy Processing Market Size by Country (US$ Million), 2021–2026
Table 34. North America Cell therapy Processing Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Cell therapy Processing Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Cell therapy Processing Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Cell therapy Processing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Cell therapy Processing Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Cell therapy Processing Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Cell therapy Processing Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Cell therapy Processing Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Cell therapy Processing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Cell therapy Processing Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Cell therapy Processing Market Size by Country (US$ Million), 2027–2032
Table 47. Anthrogenesis Corp. Company Details
Table 48. Anthrogenesis Corp. Business Overview
Table 49. Anthrogenesis Corp. Cell therapy Processing Product
Table 50. Anthrogenesis Corp. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 51. Anthrogenesis Corp. Recent Development
Table 52. BioNTech Company Details
Table 53. BioNTech Business Overview
Table 54. BioNTech Cell therapy Processing Product
Table 55. BioNTech Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 56. BioNTech Recent Development
Table 57. Cell Ideas Company Details
Table 58. Cell Ideas Business Overview
Table 59. Cell Ideas Cell therapy Processing Product
Table 60. Cell Ideas Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 61. Cell Ideas Recent Development
Table 62. Epic Sciences Company Details
Table 63. Epic Sciences Business Overview
Table 64. Epic Sciences Cell therapy Processing Product
Table 65. Epic Sciences Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 66. Epic Sciences Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Cell therapy Processing Product
Table 70. Roche Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 71. Roche Recent Development
Table 72. FuGENE Company Details
Table 73. FuGENE Business Overview
Table 74. FuGENE Cell therapy Processing Product
Table 75. FuGENE Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 76. FuGENE Recent Development
Table 77. IBC Pharmaceuticals Inc. Company Details
Table 78. IBC Pharmaceuticals Inc. Business Overview
Table 79. IBC Pharmaceuticals Inc. Cell therapy Processing Product
Table 80. IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 81. IBC Pharmaceuticals Inc. Recent Development
Table 82. Bluebird Bio Inc. Company Details
Table 83. Bluebird Bio Inc. Business Overview
Table 84. Bluebird Bio Inc. Cell therapy Processing Product
Table 85. Bluebird Bio Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 86. Bluebird Bio Inc. Recent Development
Table 87. Immodulon-Therapeutics Company Details
Table 88. Immodulon-Therapeutics Business Overview
Table 89. Immodulon-Therapeutics Cell therapy Processing Product
Table 90. Immodulon-Therapeutics Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 91. Immodulon-Therapeutics Recent Development
Table 92. Immunomedics Inc. Company Details
Table 93. Immunomedics Inc. Business Overview
Table 94. Immunomedics Inc. Cell therapy Processing Product
Table 95. Immunomedics Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 96. Immunomedics Inc. Recent Development
Table 97. Juno Therapeutics Inc. Company Details
Table 98. Juno Therapeutics Inc. Business Overview
Table 99. Juno Therapeutics Inc. Cell therapy Processing Product
Table 100. Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 101. Juno Therapeutics Inc. Recent Development
Table 102. Medlmmune Inc. Company Details
Table 103. Medlmmune Inc. Business Overview
Table 104. Medlmmune Inc. Cell therapy Processing Product
Table 105. Medlmmune Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 106. Medlmmune Inc. Recent Development
Table 107. NeoStem Oncology Company Details
Table 108. NeoStem Oncology Business Overview
Table 109. NeoStem Oncology Cell therapy Processing Product
Table 110. NeoStem Oncology Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 111. NeoStem Oncology Recent Development
Table 112. Neurotech USA Company Details
Table 113. Neurotech USA Business Overview
Table 114. Neurotech USA Cell therapy Processing Product
Table 115. Neurotech USA Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 116. Neurotech USA Recent Development
Table 117. Novartis Company Details
Table 118. Novartis Business Overview
Table 119. Novartis Cell therapy Processing Product
Table 120. Novartis Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 121. Novartis Recent Development
Table 122. Persimmune Inc. Company Details
Table 123. Persimmune Inc. Business Overview
Table 124. Persimmune Inc. Cell therapy Processing Product
Table 125. Persimmune Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 126. Persimmune Inc. Recent Development
Table 127. Pluristem Therapeutics Company Details
Table 128. Pluristem Therapeutics Business Overview
Table 129. Pluristem Therapeutics Cell therapy Processing Product
Table 130. Pluristem Therapeutics Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 131. Pluristem Therapeutics Recent Development
Table 132. BioMed Valley Discoveries Inc. Company Details
Table 133. BioMed Valley Discoveries Inc. Business Overview
Table 134. BioMed Valley Discoveries Inc. Cell therapy Processing Product
Table 135. BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 136. BioMed Valley Discoveries Inc. Recent Development
Table 137. Regeneron Pharmaceuticals Inc. Company Details
Table 138. Regeneron Pharmaceuticals Inc. Business Overview
Table 139. Regeneron Pharmaceuticals Inc. Cell therapy Processing Product
Table 140. Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 141. Regeneron Pharmaceuticals Inc. Recent Development
Table 142. UCL Business PLC. Company Details
Table 143. UCL Business PLC. Business Overview
Table 144. UCL Business PLC. Cell therapy Processing Product
Table 145. UCL Business PLC. Revenue in Cell therapy Processing Business (US$ Million), 2021–2026
Table 146. UCL Business PLC. Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. Cell therapy Processing Picture
Figure 2. Global Cell therapy Processing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cell therapy Processing Market Share by Type: 2025 vs 2032
Figure 4. Products Features
Figure 5. Services Features
Figure 6. Software Features
Figure 7. Global Cell therapy Processing Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Cell therapy Processing Market Share by Application: 2025 vs 2032
Figure 9. Cardiovascular Disease Case Studies
Figure 10. Bone Repair Case Studies
Figure 11. Neurological Disorders Case Studies
Figure 12. Skeletal Muscle RepairImmune Diseases Case Studies
Figure 13. Cell therapy Processing Report Years Considered
Figure 14. Global Cell therapy Processing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Cell therapy Processing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Cell therapy Processing Market Share by Region: 2025 vs 2032
Figure 17. Global Cell therapy Processing Market Share by Players in 2025
Figure 18. Global Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Cell therapy Processing Revenue in 2025
Figure 20. North America Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Cell therapy Processing Market Share by Country (2021–2032)
Figure 22. United States Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Cell therapy Processing Market Share by Country (2021–2032)
Figure 26. Germany Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Cell therapy Processing Market Share by Region (2021–2032)
Figure 34. China Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Cell therapy Processing Market Share by Country (2021–2032)
Figure 42. Mexico Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Cell therapy Processing Market Share by Country (2021–2032)
Figure 46. Israel Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Cell therapy Processing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Anthrogenesis Corp. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 50. BioNTech Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 51. Cell Ideas Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 52. Epic Sciences Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 53. Roche Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 54. FuGENE Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 55. IBC Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 56. Bluebird Bio Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 57. Immodulon-Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 58. Immunomedics Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 59. Juno Therapeutics Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 60. Medlmmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 61. NeoStem Oncology Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 62. Neurotech USA Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 63. Novartis Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 64. Persimmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 65. Pluristem Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 66. BioMed Valley Discoveries Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 67. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 68. UCL Business PLC. Revenue Growth Rate in Cell therapy Processing Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cell therapy Processing market?
The top companies in the global Cell therapy Processing market are Anthrogenesis Corp.、BioNTech、Cell Ideas.
Related Reports
Cell therapy Processing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell therapy Processing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 133
USD 3950.00
(Single User License)
Global Cell therapy Processing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell therapy Processing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-30
Pages: 153
USD 4900.00
(Single User License)
Global Cell therapy Processing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell therapy Processing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 104
USD 4250.00
(Single User License)
Cell therapy Processing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell therapy Processing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 136
USD 3950.00
(Single User License)
Global Cell therapy Processing Market Research Report 2025
The global market for Cell therapy Processing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 94
USD 2900.00
(Single User License)
Global Cell therapy Processing Market Insights, Forecast to 2030
Market Analysis and Insights: Global Cell therapy Processing Market
Published Date: 2024-04-25
Pages: 128
USD 4900.00
(Single User License)
Global Cell therapy Processing Market Research Report 2024
The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 101
USD 2900.00
(Single User License)
Cell therapy Processing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell therapy Processing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 133
USD 3950.00 (Single User License)Global Cell therapy Processing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell therapy Processing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-30
Pages: 153
USD 4900.00 (Single User License)Global Cell therapy Processing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell therapy Processing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 104
USD 4250.00 (Single User License)Cell therapy Processing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell therapy Processing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 136
USD 3950.00 (Single User License)Global Cell therapy Processing Market Research Report 2025
The global market for Cell therapy Processing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 94
USD 2900.00 (Single User License)Global Cell therapy Processing Market Insights, Forecast to 2030
Market Analysis and Insights: Global Cell therapy Processing Market
Published: 2024-04-25
Pages: 128
USD 4900.00 (Single User License)Global Cell therapy Processing Market Research Report 2024
The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 101
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now